Clinical trial
A Safety And Efficacy Study Of Alg-1001 In Human Subjects With Symptomatic Focal Vitreomacular Adhesion
NCT02153476 is registered in ClinicalTrials.gov with Allegro Ophthalmics, LLC as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Safety And Efficacy Study Of Alg-1001 In Human Subjects With Symptomatic Focal Vitreomacular Adhesion
- Lead sponsor
- Allegro Ophthalmics, LLC
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- February 28, 2014
- Completion date
- June 30, 2015
- Enrollment
- 45 (actual)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.
symptomatic focal vitreomacular adhesion